Petros Pharmaceuticals Inc
NASDAQ:PTPI

Watchlist Manager
Petros Pharmaceuticals Inc Logo
Petros Pharmaceuticals Inc
NASDAQ:PTPI
Watchlist
Price: 0.0092 USD -22.03% Market Closed
Market Cap: 389.8k USD

Intrinsic Value

PTPI doesn't have a meaningful market cap.

The intrinsic value of one PTPI stock under the Base Case scenario is 0.7666 USD. Compared to the current market price of 0.0092 USD, Petros Pharmaceuticals Inc is Undervalued by 99%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PTPI Intrinsic Value
0.7666 USD
Undervaluation 99%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare PTPI to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PTPI?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Petros Pharmaceuticals Inc

Current Assets 7.3m
Cash & Short-Term Investments 3.7m
Receivables 416.1k
Other Current Assets 3.2m
Non-Current Assets 3.3m
PP&E 136.7k
Intangibles 3.2m
Current Liabilities 18m
Accounts Payable 2.3m
Accrued Liabilities 8.3m
Other Current Liabilities 7.4m
Non-Current Liabilities 75.2k
Other Non-Current Liabilities 75.2k
Efficiency

Free Cash Flow Analysis
Petros Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Petros Pharmaceuticals Inc

Revenue
5.1m USD
Cost of Revenue
-1.2m USD
Gross Profit
3.9m USD
Operating Expenses
-14.2m USD
Operating Income
-10.3m USD
Other Expenses
-16.5m USD
Net Income
-26.8m USD
Fundamental Scores

PTPI Profitability Score
Profitability Due Diligence

Petros Pharmaceuticals Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
Net Margin is Increasing
19/100
Profitability
Score

Petros Pharmaceuticals Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

PTPI Solvency Score
Solvency Due Diligence

Petros Pharmaceuticals Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
28/100
Solvency
Score

Petros Pharmaceuticals Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PTPI Price Targets Summary
Petros Pharmaceuticals Inc

There are no price targets for PTPI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Petros Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PTPI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PTPI Insider Trading
Buy and sell transactions by insiders